PGRMC1 and lung carcinoma: By performing proteome analysis with a newly established erlotinib-resistant cell line, PC9/ER, derived from PC9 lung cancer cells13, we previously revealed progesterone membrane component 1 (PGRMC1) as a candidate protein involved in acquired resistance to erlotinib.